| Filing date | Description | Form | View |
|---|---|---|---|
Statement of changes in beneficial ownership of securities |
4 | View HTML | |
An amendment to the SC 13G filing |
SC 13G/A | View HTML | |
An amendment to the SC 13G filing |
SC 13G/A | View HTML | |
An amendment to the SC 13G filing |
SC 13G/A | View HTML | |
An amendment to the SC 13G filing |
SC 13G/A | View HTML | |
An amendment to the SC 13G filing |
SC 13G/A | View HTML | |
A statement of beneficial ownership of common stock by certain persons |
SC 13G | View HTML | |
POSASR |
POSASR | View HTML | |
Report of unscheduled material events or corporate event |
8-K | EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML | |
Annual report which provides a comprehensive overview of the company for the past year |
10-K | EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML |
Data provided by Kaleidoscope.
2022
2021
Thursday, May 4, 2023, at 9:00 AM Pacific Time
The 2023 Annual Meeting of Stockholders of Nurix Therapeutics, Inc. (“Nurix” or the “Company”) was held on Thursday, May 4, 2023.
Stockholders of record of Nurix common stock as of the close of business on March 10, 2023, were entitled to vote at the meeting. A replay of the webcast of the meeting will be accessible by visiting www.virtualshareholdermeeting.com/NRIX2023.
The date, time and location of our 2024 Annual Meeting of Stockholders will be announced in our annual proxy statement filed with the SEC and will be available at the SEC Filings page found within the “Investors” section of our website.
'